Thematic Section on Muscle Satellite Cells in Health and Disease

25-07-2023

Dear Colleagues,

Skeletal muscle is capable of self-repair and locally regenerates by resident stem cells, named satellite cells, which ensure lifetime muscle fiber homeostasis, hypertrophy, repair, and regeneration. Poor satellite cell function has great implications for muscle health and has recently been associated with a new class of neuromuscular conditions named Satellite Cell-opathies (https://doi.org/10.4081/ejtm.2022.10064).

With the Satellite cells recently entering their 6th decade since the discovery, the European Journal of Translational Myology (EJTM) is delighted  to dedicate a thematic section to this essential cell population, while celebrating the journal's recently achieved impact factor: EJTM has obtained an IF of 2.2 and a 5-year value of 2.1 (ranking 130/189, Q3 percentile in Clarivate’s MEDICINE, RESEARCH, AND EXPERIMENTAL category).

The main purpose of this thematic section, titled ‘Muscle Satellite Cells in Health and Disease’, is to gather new experimental insights or challenging review articles that aim to shed light on the intricate cellular and molecular mechanisms governing the role of satellite cells in maintaining skeletal muscle homeostasis.  The collection will contribute to a better understanding of the function of muscle stem cells in tissue development and regeneration in health and disease, possibly proposing potential therapeutic approaches for pathological conditions where muscle homeostasis is compromised.

Article Processing Charges

All articles published in EJTM are published as open access. An article processing charge (APC) of 350,00€ applies to papers accepted after peer review. This article processing charge is to cover the costs of peer review emailing, copyediting, typesetting, and long-term archiving.

The fee of 350,00€ is applicable to all papers submitted until December 15th, 2023. The Journal intends to raise the publication costs for all papers after that date.

 

Submit your paper HERE

 

Benefits of publishing in EJTM

  • Multifaceted portfolio, including various perspectives in myology: basic, cellular and molecular, genetic, clinical, and translational.
  • Manuscripts are published and forwarded to PubMed as soon as they have been accepted, so there are no delays in getting your research available to the scientific community.
  • Commitment to diversity, equity, and inclusion, including demographic diversity among peer reviewers.

Sincerely,

Ugo Carraro, Editor-in-Chief ugo.carraro@unipd.it

July 30, 2023

 

Guest Editors

Massimo Ganassi, King’s College London, London, UK massimo.ganassi@kcl.ac.uk

Zipora Yablonka-Reuveni, University of Washington School of Medicine, Seattle, WA, USA  reuveni@u.washington.edu